{
    "ticker": "EGRX",
    "name": "Eagle Pharmaceuticals, Inc.",
    "description": "Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable products. Founded in 2013, Eagle is committed to addressing the unmet medical needs of patients and healthcare providers through the creation of high-quality, affordable medications. The company's portfolio includes a range of products, particularly in the oncology and critical care therapeutic areas, with a strong emphasis on improving patient outcomes. Eagle Pharmaceuticals utilizes its proprietary technologies to enhance the delivery of established drugs, positioning itself as a leader in the field of injectable pharmaceuticals. The company is dedicated to advancing patient care by providing alternatives to traditional therapies that can be more effective and easier to administer. Eagle has a robust pipeline of products in various stages of development, demonstrating its commitment to innovation and growth in the pharmaceutical industry. With a mission to provide better healthcare solutions, Eagle Pharmaceuticals continues to expand its market presence and deliver value to patients, healthcare providers, and stakeholders alike.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Woodcliff Lake, New Jersey, USA",
    "founded": "2013",
    "website": "https://www.eagleus.com",
    "ceo": "Scott Tarriff",
    "social_media": {
        "twitter": "https://twitter.com/EaglePharma",
        "linkedin": "https://www.linkedin.com/company/eagle-pharmaceuticals/"
    },
    "investor_relations": "https://investors.eagleus.com",
    "key_executives": [
        {
            "name": "Scott Tarriff",
            "position": "CEO"
        },
        {
            "name": "Rajiv K. Khosla",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Injectable Pharmaceuticals",
            "products": [
                "Eagle's Bendamustine",
                "Eagle's Ephedrine"
            ]
        }
    ],
    "seo": {
        "meta_title": "Eagle Pharmaceuticals, Inc. | Specialty Injectable Products",
        "meta_description": "Discover Eagle Pharmaceuticals, Inc., a leader in specialty pharmaceuticals focused on innovative injectable products aimed at improving patient care.",
        "keywords": [
            "Eagle Pharmaceuticals",
            "Injectable Drugs",
            "Pharmaceuticals",
            "Oncology",
            "Specialty Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What does Eagle Pharmaceuticals specialize in?",
            "answer": "Eagle Pharmaceuticals specializes in developing and commercializing innovative injectable medications."
        },
        {
            "question": "Who is the CEO of Eagle Pharmaceuticals?",
            "answer": "Scott Tarriff is the CEO of Eagle Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Eagle Pharmaceuticals headquartered?",
            "answer": "Eagle Pharmaceuticals is headquartered in Woodcliff Lake, New Jersey, USA."
        },
        {
            "question": "What types of products does Eagle Pharmaceuticals offer?",
            "answer": "Eagle Pharmaceuticals offers a range of injectable pharmaceuticals, particularly in oncology and critical care."
        },
        {
            "question": "When was Eagle Pharmaceuticals founded?",
            "answer": "Eagle Pharmaceuticals was founded in 2013."
        }
    ],
    "competitors": [
        "AMGN",
        "BMY",
        "GILD",
        "HIG"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}